LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 9 of 15: Cell count and normalized growth rate inhibition values within biological replicate 2. - Dataset - HMS LINCS Database

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 9 of 15: Cell count and normalized growth rate inhibition values within biological replicate 2. - Dataset (ID:20246)

Download: Excel (XLSX), Comma-separated (CSV)

<<<<

Select the entities to show:

Small molecules	Cells

|<
<<
Previous
Page 312 of 520
Next
>>
>
7776 to 7800 of 12982 records
per page:

Cell	Small Molecule	Small Mol Concentration	Small Mol Conc Unit	LJP Library Plate	Replicate	Assay Well	Timepoint	Timepoint Unit	Total Cell Count Before Treatment	Total Cell Count After Treatment	Total Control Cell Count	Relative Cell Count	Normalized Growth Rate Inhibition Value
BT-20	SNS-032	3.33	uM	LJP6	2	H14	72	hr	1334	394	3899	0.1011	-0.5456
BT-20	SNS-032	3.33	uM	LJP6	3	H14	72	hr	1334	401	3921	0.1023	-0.5385
BT-20	SNS-032	10	uM	LJP6	1	H13	72	hr	1334	361	3955	0.0913	-0.5658
BT-20	SNS-032	10	uM	LJP6	2	H13	72	hr	1334	406	3899	0.1041	-0.5367
BT-20	SNS-032	10	uM	LJP6	3	H13	72	hr	1334	499	3921	0.1273	-0.4689
BT-20	Afatinib	0.04	uM	LJP6	1	G24	72	hr	1334	2876	3955	0.7270	0.6320
BT-20	Afatinib	0.04	uM	LJP6	2	G24	72	hr	1334	3293	3899	0.8445	0.7930
BT-20	Afatinib	0.04	uM	LJP6	3	G24	72	hr	1334	2983	3921	0.7607	0.6774
BT-20	Afatinib	0.12	uM	LJP6	1	G23	72	hr	1334	3258	3955	0.8236	0.7671
BT-20	Afatinib	0.12	uM	LJP6	2	G23	72	hr	1334	3136	3899	0.8043	0.7373
BT-20	Afatinib	0.12	uM	LJP6	3	G23	72	hr	1334	3349	3921	0.8540	0.8070
BT-20	Afatinib	0.37	uM	LJP6	1	G22	72	hr	1334	3249	3955	0.8213	0.7640
BT-20	Afatinib	0.37	uM	LJP6	2	G22	72	hr	1334	3504	3899	0.8987	0.8665
BT-20	Afatinib	0.37	uM	LJP6	3	G22	72	hr	1334	3162	3921	0.8064	0.7415
BT-20	Afatinib	1.11	uM	LJP6	1	G21	72	hr	1334	3738	3955	0.9450	0.9290
BT-20	Afatinib	1.11	uM	LJP6	2	G21	72	hr	1334	3289	3899	0.8435	0.7916
BT-20	Afatinib	1.11	uM	LJP6	3	G21	72	hr	1334	3301	3921	0.8418	0.7903
BT-20	Afatinib	3.33	uM	LJP6	1	G20	72	hr	1334	3554	3955	0.8984	0.8679
BT-20	Afatinib	3.33	uM	LJP6	2	G20	72	hr	1334	3446	3899	0.8838	0.8465
BT-20	Afatinib	3.33	uM	LJP6	3	G20	72	hr	1334	3133	3921	0.7990	0.7312
BT-20	Afatinib	10	uM	LJP6	1	G19	72	hr	1334	1779	3955	0.4497	0.2012
BT-20	Afatinib	10	uM	LJP6	2	G19	72	hr	1334	2288	3899	0.5868	0.4169
BT-20	Afatinib	10	uM	LJP6	3	G19	72	hr	1334	2178	3921	0.5554	0.3702
BT-20	GSK1904529A	0.04	uM	LJP6	1	H24	72	hr	1334	3149	3955	0.7961	0.7292
BT-20	GSK1904529A	0.04	uM	LJP6	2	H24	72	hr	1334	3271	3899	0.8389	0.7853

|<
<<
Previous
Page 312 of 520
Next
>>
>
7776 to 7800 of 12982 records
per page:

HMS LINCS Project

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 9 of 15: Cell count and normalized growth rate inhibition values within biological replicate 2. - Dataset (ID:20246)